←

Trustworthy scientific resources

2025-11-23 - last updated: 2026-09-29 scienceresources

I have to admit, most scientific papers about psychedelics are pretty dry to read. A lot of them are about dosing schedules, statistics, or how the next study should be designed, which is all very important work, but not something that will make you go "wow" on a Sunday afternoon.

But every now and then one comes along that makes me sit up straight! A study where two thirds of the people call a single mushroom session one of the most meaningful days of their life. Researchers asking thousands of people about the beings they met on DMT, and taking their answers seriously. Old mice growing their fur back. Veterans with brain injuries walking out of an ibogaine clinic in a way no one expected.

Those are the ones I collected here. I tried to pick things you can read (or at least skim) without a science degree, and I wrote a little bit about each one in plain words, so you can decide for yourself which ones you'd like to open.

One thing to keep in mind: research can tell you what happened to a lot of people, but it can't tell you what your own journey will be like. That part stays a mystery, and for me that's very much part of the beauty of it ♡


Where it all happens

The Mushroom studies I keep coming back to

  • Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (Griffiths et al., 2006)
    The one that started the modern wave. 36 healthy volunteers who had never taken a psychedelic got one session with psilocybin in a calm, living-room-like space. Two months later, about two thirds of them rated it among the five most meaningful experiences of their whole life, and a third called it the single most meaningful one. People compared it to the birth of their first child. I still get goosebumps from that.

  • Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer (Griffiths et al., 2016)
    51 people with a cancer diagnosis, many of them afraid of dying, each got one high-dose session with good support. Six months later, about 80% still had much lower depression and anxiety than before. A lot of them described something like making peace with death.

  • Pilot study of psilocybin in the treatment of tobacco addiction (Johnson et al., 2014)
    A small study with 15 long-time smokers, some of whom had tried to quit many many times. Six months later, 12 of them (80%) were still not smoking. It's a tiny group, so it's more of a hopeful first peek than proof, but for comparison: even the best quit-smoking medicines usually stay below 35%.

  • Psilocybin for alcohol use disorder (Bogenschutz et al., 2022)
    A proper randomised trial with 95 people. Over the eight months after treatment, the group that got psilocybin had less than half as many heavy drinking days as the group that got a placebo.

  • Religious leaders and psilocybin (Johns Hopkins and NYU, published 2025)
    This one makes me smile. 24 clergy from different traditions (rabbis, Christian ministers, a Catholic priest, a Muslim leader...) each got two sessions. Afterwards 96% of them counted it among the five most spiritually significant experiences of their life, and many said it made them better at their work. It wasn't all bliss though: 42% also called it one of the most challenging experiences they ever had. NPR wrote a lovely piece about it, including a few who ended up switching careers!

What happens in the brain (and in some very old mice)

  • Psilocybin desynchronizes the human brain (Siegel et al., Nature, 2024)
    The researchers scanned the same few people over and over, before, during and after psilocybin. During the trip, the brain network that holds our everyday sense of "me" (the default mode network) basically fell out of sync, much more than with a stimulant they used for comparison. The part I find most exciting: one connection, between that network and the memory center of the brain, stayed looser for weeks afterwards. That might be part of why a single session can leave a door open for so long.

  • Psilocybin treatment extends cellular lifespan and improves survival of aged mice (Kato et al., 2025)
    Old mice (the human equivalent of about 60 to 65 years) got a monthly dose of psilocybin. After ten months, 80% of them were still alive, against 50% in the group without. They even grew back fur and had less grey! Human cells in a dish also lived longer. Now, mice are not people, and in 2026 someone wrote a cheeky little reply pointing out that famous psychedelic pioneers didn't live noticeably longer than famous cancer researchers. So I'm treating this as a fun curiosity for now, but a very fun one.

Outside the lab

  • Oregon's legal psilocybin services (Korthuis et al., JAMA Network Open, 2026)
    This one is close to my heart, because it's about what I do: not a hospital, but guided journeys with a trained facilitator. Oregon has allowed this since 2023, and researchers followed 346 people. One month later 91.5% said it had benefited them, and about 65% counted it among the ten most meaningful experiences of their life. It doesn't leave out the other side either: 2% said it had been harmful to them, and four people who were trying it for the first time had reactions that needed medical attention. The researchers found the safety very similar to clinical trials.

  • Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression (Breeksema et al., 2024)
    A Dutch study (from Groningen) that simply asked patients what it was like. What I love about it is that it's so honest: people talk about how hard it can be to surrender, how much the music mattered, and how they wished for more time to build trust beforehand and more support afterwards. It's one of the reasons I take the preparation and the talks after a journey so seriously.

  • Johns Hopkins Scientists Give Psychedelics the Serious Treatment (Scientific American, 2020)
    A friendly long read about what a session in the Hopkins studies actually looks like, with the eyeshades, the music and the guides sitting beside you.

  • Do You Need to 'Trip' for Psychedelics to Work as Medicine? (Scientific American podcast, 2023)
    Some companies are trying to make psychedelic medicines without the trip. This episode lets both sides talk. (I think you can guess which side my heart is on, but it's a really interesting listen!)

DMT, and the beings people meet there

DMT is a very short and very intense psychedelic (smoked, it lasts around 10 to 15 minutes), and it's also the active ingredient in ayahuasca. What makes it so special to researchers is how often people describe meeting someone there: beings, guides, 'machine elves', presences that seem to know them. For a long time science simply didn't touch this. That's changing, and I find it one of the most exciting corners of the whole field.

  • Rick Strassman's DMT studies (1990 to 1995)
    The first US government-approved psychedelic research in over 20 years. Strassman gave DMT to about 60 volunteers in a hospital in New Mexico, and a lot of them came back talking about entities, often in very similar ways, even though they didn't know each other. The original scientific paper is quite technical, but his book DMT: The Spirit Molecule tells the whole story in a very readable way, including how the experiences surprised him. (You can also read his text about preparing for a journey here on my site!)

  • Survey of entity encounter experiences occasioned by inhaled DMT (Davis et al., Johns Hopkins, 2020)
    Over 2,500 people described the most memorable being they met on DMT. The most common words they used were "being", "guide", "spirit", "alien" and "helper". Almost all of them (96%) felt it was conscious and intelligent, most felt love, joy or trust from it, and many said it still felt real afterwards. And this one surprised me: of the people who called themselves atheist before the encounter, more than half no longer did after.

  • DMT models the near-death experience (Timmermann et al., 2018) and An encounter with death (Michael et al., 2025)
    Two studies comparing DMT trips with the stories of people who nearly died. There's a lot of overlap: bright light, the feeling of passing through something, meeting beings, the sense of dying. The 2025 study also found an interesting difference: people near death tend to meet deceased loved ones or religious figures, while on DMT it's more often guides and 'alien' beings.

  • A model for a prolonged immersive DMT experience (Gallimore & Strassman, 2016) and Psychological and physiological effects of extended DMT (Luan et al., Imperial, 2023)
    Because a DMT trip is over so fast, it's hard to study what's happening "over there". So Andrew Gallimore and Rick Strassman worked out how a slow IV drip could keep someone in the DMT space for much longer, like the way anaesthesia is kept steady during surgery. A few years later Imperial actually tried it and kept people there for 30 minutes, and it was well tolerated. They call it DMTx (extended-state DMT).

  • Traces of the Other: Are DMT entities real? (Gallimore, Hoffman & Hermansson, 2026, preprint)
    Okay, this is the wild one. Gallimore teamed up with cognitive scientist Donald Hoffman, who thinks consciousness (not matter) is the most basic stuff of reality. Together they propose that DMT might let us perceive traces of other conscious beings that are normally filtered out. And they want to test it! For example: someone in extended-state DMT asks an entity for a colour that was randomly picked in a sealed room, or two people in separate rooms try to pass a word to each other through the same being. If nothing comes through, that counts as evidence against their idea. It's a preprint, meaning it hasn't been peer-reviewed yet, but I love that someone is taking the question this seriously. Here's a readable summary.

  • Computational spirits: a neuroscientific account of psychedelic entity encounters (Mago et al., 2026)
    And for balance, a team including Robin Carhart-Harris and Christopher Timmermann explains entity encounters from the brain's side: the brain suddenly has so much rich, complex experience to make sense of, while its usual way of telling "this comes from me" apart from "this comes from outside" is loosened up. That combination might be exactly what a meeting with a separate being feels like. It could also explain why the beings look so different from culture to culture.

(For me personally, these beings feel very real, but that's my truth! I'd much rather you read both sides, and maybe one day meet them yourself, and see what feels true for you ✨)

Ibogaine, the root from Central Africa

Ibogaine comes from the root bark of the iboga shrub, which has been used for a very long time in the Bwiti tradition in Gabon. It's a very long and very intense journey (often more than a day), and it's known for something almost unbelievable: many people coming off opioids say their withdrawal symptoms largely disappear after one session.

  • Magnesium–ibogaine therapy in veterans with traumatic brain injuries (Cherian et al., Stanford, Nature Medicine, 2024)
    30 US special forces veterans with brain injuries from blasts got one ibogaine treatment in a clinic in Mexico. A month later their PTSD, depression and anxiety scores had dropped by more than 80% on average, and their disability scores went from 'mild to moderate' to basically none. Their thinking and concentration improved too.

  • Accelerated recovery using magnesium ibogaine (Olash et al., 2026)
    The same veterans, but now in their own words. They talk about reliving old memories with a completely different feeling, forgiveness, waves of love for themselves and others, and some even felt their brain being repaired. The researchers call it a kind of "auto-psychotherapy", where a lot of the inner work seemed to happen by itself during that one very long night.

These results made quite a splash: in 2026 the US government set aside at least $50 million for ibogaine research, and Texas started funding trials as well.

But please take this part seriously ♡ Ibogaine is a very different substance from the Mushroom. It can disturb the rhythm of the heart, and people have died from it, especially without medical screening or when combined with other drugs. That's why the Stanford team gave magnesium alongside it and had doctors monitoring the heart the whole time. It's not something I guide, and it's only something to do with proper medical care around you.

Books to curl up with

  • How to Change Your Mind by Michael Pollan: the friendliest introduction there is, also as a Netflix series.
  • The Psychedelic Explorer's Guide by James Fadiman: the book my own way of guiding is based on. (You can read his guidelines for voyagers here!)
  • DMT: The Spirit Molecule by Rick Strassman: the full story of his DMT research, from someone who didn't expect to find what he found.
  • Death by Astonishment and Alien Information Theory by Andrew Gallimore: for when you want to go all the way into the DMT world. Quite brainy, but so much fun.
  • The Doors of Perception by Aldous Huxley: short, old and still beautiful.

For a bigger list with documentaries and more, have a look at my resource list.


For your peace of mind: how safe is psilocybin?

This is often the first question people ask me, and I get it! So here is what the research says, as plainly as I can put it. The short version: physically, psilocybin is one of the safest substances we know. The real risks are mostly about the mind and about the situation you're in, and that's exactly where good preparation and a sober guide make a big difference.

Your body

  • You can't realistically overdose on it. In a well-known comparison of drugs (Gable, 2004), the gap between a normal dose and a dangerous one was about 6 times for heroin, about 10 times for alcohol, and around 1000 times for psilocybin. A large review from 2023 found no clear dose at which psilocybin itself becomes life-threatening, and only two (disputed) deaths in the entire medical literature.
  • It isn't addictive. It doesn't make you crave more, and taking it again soon after actually makes it work much less.
  • It's among the least harmful drugs overall. When a panel of experts led by David Nutt ranked 20 drugs on all the harm they do to users and to others, magic mushrooms came out as the least harmful, and alcohol as the most harmful.
  • Your heart rate and blood pressure go up a little during the journey. For most people that's no problem, but it's one of the things we look at together during screening.

Your mind

  • The effects wear off. A journey lasts about 4 to 6 hours, and then you come back.
  • Hard moments can happen. In the clergy study above, almost half called it one of the most challenging experiences of their life, and still most of them were very glad they did it. For me, difficult moments aren't random, and you're not alone in them: they're often exactly where something wants to be seen.
  • Not everyone should take it. People with (a family history of) psychosis, schizophrenia or bipolar disorder have a higher risk of it triggering something serious, and some medications don't combine well. That's why the Johns Hopkins safety guidelines screen for this, and why I do too. Screening lowers the risk a lot, but no one can bring it all the way down to zero.
  • The situation matters. A lot of what can go wrong is about the situation: someone confused and on their own, or in a busy place with no one looking out for them. The Oregon study found the same: the people who needed medical help were first-timers. A calm, safe space with someone sober beside you takes away a big part of this risk.
  • Lasting visual effects are rare. A small number of people report visual changes that stick around after a journey (called HPPD). It's rare, and usually mild.
  • In large population studies, people who had used psychedelics weren't more likely to have mental health problems than people who hadn't, and on some measures they were even doing a bit better.

So the Mushroom asks for respect, and with good preparation there is a lot less to be scared of than the old stories make it seem. And if you have a specific worry, just ask me, I'd love to talk it through with you 😊


Keep wandering

This field moves fast! Since the first version of this page, a whole bunch of new studies came out, and some of the older ones got questioned too. So I'll keep updating this page every now and then, and it's always worth checking the sources above yourself to see what's new.

Whenever you feel ready, or just curious, send me a message and we'll have a first chat ♡

With love,
Jiri

P.S. If you only have time for one thing on this page, read the 2006 Griffiths study. It's short and surprisingly readable, and it's where so much of this started 🍄